BRAF and neoplasm: Moreover, answering these questions will be key for a successful targeted therapy as an incomplete inhibition of a highly active BRAF oncoprotein triggering OIS instead of cell death in the majority of tumor cells might allow cell cycle re-entry and tumor expansion instead.